{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:24:34Z","timestamp":1787066674175,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bioorg.2021.105540","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T02:13:49Z","timestamp":1638843229000},"page":"105540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Synthesis and structure activity relationship of the first class of LXR inverse agonists"],"prefix":"10.1016","volume":"119","author":[{"given":"Bahaa","family":"Elgendy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Griffett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamees","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Di Fruscia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirby","family":"Sample","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmalie","family":"Schoepke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore M.","family":"Kamenecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Burris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bioorg.2021.105540_b0005","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0168-9525(01)02417-9","article-title":"How many nuclear hormone receptors are there in the human genome?","volume":"17","author":"Robinson-Rechavi","year":"2001","journal-title":"Trends Genet."},{"issue":"11","key":"10.1016\/j.bioorg.2021.105540_b0010","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nrd1551","article-title":"Principles for modulation of the nuclear receptor superfamily","volume":"3","author":"Gronemeyer","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2021.105540_b0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/jme.0.0190207","article-title":"Evolution of the nuclear receptor superfamily: Early diversification from an ancestral orphan receptor","volume":"19","author":"Laudet","year":"1997","journal-title":"J. Mol. Endocrinol."},{"issue":"12","key":"10.1016\/j.bioorg.2021.105540_b0020","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1074\/jbc.M109771200","article-title":"Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis","volume":"277","author":"Tobin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2021.105540_b0025","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1210\/mend.16.6.0835","article-title":"Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system","volume":"16","author":"Whitney","year":"2002","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105540_b0030","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tem.2016.03.018","article-title":"LXR Regulation of Brain Cholesterol: From Development to Disease","volume":"27","author":"Courtney","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105540_b0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cell.2008.04.052","article-title":"LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response","volume":"134","author":"Bensinger","year":"2008","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bioorg.2021.105540_b0040","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bbadis.2010.12.015","article-title":"Liver X receptors as regulators of macrophage inflammatory and metabolic pathways","volume":"1812","author":"A-Gonz\u00e1lez","year":"2011","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.bioorg.2021.105540_b0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/molecules22010088","article-title":"Ligands of Therapeutic Utility for the Liver X Receptors","volume":"22","author":"Komati","year":"2017","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bioorg.2021.105540_b0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrd4280","article-title":"Liver X receptors in lipid metabolism: opportunities for drug discovery","volume":"13","author":"Hong","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2021.105540_b0055","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI27883","article-title":"Review series Liver X receptors as integrators of metabolic and inflammatory signaling","volume":"116","author":"Zelcer","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105540_b0060","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00018-003-2290-x","article-title":"Vitamin A and the regulation of fat reserves","volume":"60","author":"Bonet","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2021.105540_b0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/1568010042634541","article-title":"Nuclear receptors: overview and classification","volume":"3","author":"Novac","year":"2004","journal-title":"Curr. Drug Targets. Inflamm. Allergy."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105540_b0070","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1101\/gad.9.9.1033","article-title":"LXR, a nuclear receptor that defines a distinct retinoid response pathway","volume":"9","author":"Willy","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2021.105540_b0075","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bioorg.2021.105540_b0080","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1074\/jbc.272.6.3137","article-title":"Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway","volume":"272","author":"Lehmann","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105540_b0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1537-1891(02)00175-1","article-title":"LXRs; oxysterol activated nuclear receptors that regulate genes controlling lipid homeostasis","volume":"38","author":"Edwards","year":"2002","journal-title":"Vascul. Pharmacol."},{"issue":"24","key":"10.1016\/j.bioorg.2021.105540_b0090","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1021\/acs.jmedchem.8b00045","article-title":"Recent Advances in the Medicinal Chemistry of Liver X Receptors","volume":"61","author":"El-Gendy","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105540_b0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2015.05.007","article-title":"Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis","volume":"28","author":"Flaveny","year":"2015","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bioorg.2021.105540_b0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10989-013-9349-9","article-title":"Role of Tissue Liver X-Receptors Level in Skin Diseases","volume":"19","author":"Bedewi","year":"2013","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105540_b0105","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/art.22528","article-title":"Liver X receptor is a therapeutic target in collagen-induced arthritis","volume":"56","author":"Chintalacharuvu","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105540_b0110","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1124\/mol.108.048538","article-title":"The Selective Alzheimer\u2019s Disease Indicator-1 Gene (Seladin-1\/DHCR24) Is a Liver X Receptor Target Gene","volume":"74","author":"Wang","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105540_b0115","doi-asserted-by":"crossref","first-page":"13112","DOI":"10.1073\/pnas.1210833109","article-title":"Liver X receptor \u03b2 protects dopaminergic neurons in a mouse model of Parkinson disease","volume":"109","author":"Dai","year":"2012","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.bioorg.2021.105540_b0120","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.neuron.2016.04.039","article-title":"Nuclear Receptor NR1H3 in Familial Multiple Sclerosis","volume":"90","author":"Wang","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.bioorg.2021.105540_b0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biocel.2016.07.007","article-title":"LXR agonist regulates the proliferation and apoptosis of human T-Cell acute lymphoblastic leukemia cells via the SOCS3 pathway","volume":"78","author":"Zhang","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bioorg.2021.105540_b0130","first-page":"1","article-title":"LXR \u03b2 subcellular localization: a new tool to investigate cancer cell response to LXR ligand-induced cytotoxicity?","volume":"3","author":"Derang\u00e8re","year":"2016","journal-title":"Cancer Cell Microenviron."},{"key":"10.1016\/j.bioorg.2021.105540_b0135","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1158\/0008-5472.CAN-15-1734","article-title":"Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs\/SREBP-1c\/FAS Signaling Cascade","volume":"76","author":"Zhao","year":"2016","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105540_b0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrc3912","article-title":"Targeting liver X receptors in cancer therapeutics","volume":"15","author":"Lin","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2021.105540_b0145","first-page":"3783","article-title":"Macrophage apolipoprotein e and proliferation of MCF-7 breast cancer cells: Role of LXR","volume":"33","author":"El Roz","year":"2013","journal-title":"Anticancer Res."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105540_b0150","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1021\/jm0255116","article-title":"Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines","volume":"45","author":"Collins","year":"2002","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2021.105540_b0155","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.850400","article-title":"Role of LXRs in control of lipogenesis","volume":"14","author":"Schultz","year":"2000","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.bioorg.2021.105540_b0160","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1021\/jm901797p","article-title":"Discovery of tertiary sulfonamides as potent liver X receptor antagonists","volume":"53","author":"Zuercher","year":"2010","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105540_b0165","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cb300541g","article-title":"A liver-selective LXR inverse agonist that suppresses hepatic steatosis","volume":"8","author":"Griffett","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2021.105540_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104079","article-title":"Modulation of estrogen-related receptors subtype selectivity: Conversion of an ERR\u03b2\/\u03b3 selective agonist to ERR\u03b1\/\u03b2\/\u03b3 pan agonists","volume":"102","author":"Shahien","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105540_b0175","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bmcl.2018.12.025","article-title":"Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffold, Bioorganic Med","volume":"29","author":"Goher","year":"2019","journal-title":"Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105540_b0180","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6759","article-title":"Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour","volume":"5","author":"Banerjee","year":"2014","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105540_b0185","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bmcl.2012.11.025","article-title":"Small molecule amides as potent ROR-\u03b3 selective modulators","volume":"23","author":"Khan","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"29","key":"10.1016\/j.bioorg.2021.105540_b0190","doi-asserted-by":"crossref","first-page":"27138","DOI":"10.1074\/jbc.M302260200","article-title":"X-ray crystal structure of the liver X receptor \u03b2 ligand binding domain: Regulation by a histidine-tryptophan switch","volume":"278","author":"Williams","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105540_b0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1654-6","article-title":"Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?","volume":"10","author":"Wu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105540_b0200","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2015.03.002","article-title":"Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer","volume":"21","author":"Bovenga","year":"2015","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105540_b0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/wcms.1121","article-title":"An overview of the Amber biomolecular simulation package","volume":"3","author":"Salomon-Ferrer","year":"2013","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105540_b0210","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and Testing of a General Amber Force Field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comp. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105540_b0215","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P","article-title":"Efficient Generation of High-Quality Atomic Charges. AM1-BCC Model: I. Method","volume":"21","author":"Jakalian","year":"2000","journal-title":"J. Comp. Chem."},{"key":"10.1016\/j.bioorg.2021.105540_b0220","doi-asserted-by":"crossref","unstructured":"D.A. Ponder, J.W. Case, Force fields for protein simulations, 66 (2003) 27\u201385.","DOI":"10.1016\/S0065-3233(03)66002-X"},{"issue":"9","key":"10.1016\/j.bioorg.2021.105540_b0225","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/ct400314y","article-title":"Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald","volume":"9","author":"Salomon-Ferrer","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"13","key":"10.1016\/j.bioorg.2021.105540_b0230","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821009184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821009184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:23:37Z","timestamp":1758615817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821009184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":46,"alternative-id":["S0045206821009184"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105540","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and structure activity relationship of the first class of LXR inverse agonists","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105540"}}